Dulcolax and Fulvestrant drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dulcolax (bisacodyl) and Fulvestrant (fulvestrant). Common drug interactions include cough among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Dulcolax and Fulvestrant. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Dulcolax?

Dulcolax has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 12,897 Dulcolax users. Check the latest studies of Dulcolax.

What is Fulvestrant?

Fulvestrant has active ingredients of fulvestrant. eHealthMe is studying from 15,769 Fulvestrant users. Check the latest studies of Fulvestrant.

On Jul, 10, 2026

25 people who take Dulcolax and Fulvestrant together, and have interactions are studied.

Dulcolax and Fulvestrant drug interactions.

What are the common drug interactions of Dulcolax and Fulvestrant, by gender? *:

female:

Cough
Fatigue (feeling of tiredness)
Pain
Pain in extremity
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Chest pain
Depression
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Femur fracture
Foot fracture

male:

Abdominal distension
Abdominal hernia
Bone pain
Cervicitis (inflammation of the uterine cervix)
Chest pain
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Cough
Cutis laxa (connective tissue disorder in which the skin lacks elasticity and hangs in loose folds)
Death
Dehydration (dryness resulting from the removal of water)

What are the common drug interactions of Dulcolax and Fulvestrant, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Abdominal distension
Abdominal hernia
Abdominal pain
Arthralgia (joint pain)
Back pain
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Bone pain
Breast cancer
Cervicitis (inflammation of the uterine cervix)

40-49:

Vomiting
Weight decreased
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Arthropathy
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Exposed bone in jaw
Gingival swelling (gums swelling)
Histoplasmosis (infection caused by breathing in spores of a fungus)
Hot flush (sudden feelings of heat)
Infectious peritonitis (inflammation of the peritoneum, typically caused by bacterial infection)

50-59:

Asthenia (weakness)
Back pain
Groin pain
Pain
Pain in extremity
Pneumonia

60+:

Arthralgia (joint pain)
Back pain
Death
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Dehydration (dryness resulting from the removal of water)
Escherichia infection (bacterial infection by escherichia coli)
Fatigue (feeling of tiredness)
Full blood count decreased
Nausea (feeling of having an urge to vomit)
Pyelonephritis (inflammation of kidney caused by bacteria)

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 8 people, 32.00%
Bone Loss: 8 people, 32.00%
Breast Cancer Female: 7 people, 28.00%
Breast Cancer Metastatic: 7 people, 28.00%
Nausea (feeling of having an urge to vomit): 4 people, 16.00%
Sinus Pain: 2 people, 8.00%
Fever: 2 people, 8.00%
Back Pain: 2 people, 8.00%
Cardiac Failure Congestive: 2 people, 8.00%
Diabetes: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Dulcolax and Fulvestrant?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously